DOI: 10.1055/s-00000004

Aktuelle Neurologie

References

Coles AJ, Fox E, Vladic A. et al.
Alemtuzumab more effective than interferon β-1a at 5-year follow-up of CAMMS223 clinical trial.

Neurology 2012;
78: 1069-1078

Download Bibliographical Data

Access:
Access: